✦ LIBER ✦

Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)

✍ Scribed by C.P. Belani; G. Goss; G. Blumenschein Jr.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Promising Developments in Targeted Thera

✍ Desirée Hao; Manuel Hidalgo 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 464 KB

SP 135 Biomarkers for targeted therapy s

✍ L. Paz-Ares 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Combination of docetaxel and carboplatin

✍ Bando, H; Miyata, J; Sano, T; Sumitomo, M; Nagano, T 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Vaccines in non-small cell lung cancer:

✍ Tommaso De Pas; Monica Giovannini; Maria Rescigno; Chiara Catania; Francesca Tof 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 434 KB

The Role of Targeted Agents in the Treat

✍ Taofeek K. Owonikoko; Suresh Ramalingam 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 204 KB

Æ-941, an inhibitor of angiogenesis: rat

✍ W.K. Evans; J. Latreille; G. Batist; P. Falardeau; P. Champagne; M. Rivière; E. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 166 KB